Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells

被引:945
作者
Fuertes, Mercedes B. [1 ,2 ]
Kacha, Aalok K. [1 ,2 ]
Kline, Justin [1 ,2 ]
Woo, Seng-Ryong [1 ,2 ]
Kranz, David M. [3 ]
Murphy, Kenneth M. [4 ]
Gajewski, Thomas F. [1 ,2 ]
机构
[1] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Med, Sect Hematol Oncol, Chicago, IL 60637 USA
[3] Univ Illinois, Champaign, IL 61820 USA
[4] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA
关键词
COLONY-STIMULATING FACTOR; INNATE IMMUNE-RESPONSE; DYING CELLS; METASTATIC MELANOMA; INTERFERON-ALPHA; PROSTATE-CANCER; TUMOR-ANTIGENS; LYMPHOCYTES-T; REJECTION; RECEPTOR;
D O I
10.1084/jem.20101159
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Despite lack of tumor control in many models, spontaneous T cell priming occurs frequently in response to a growing tumor. However, the innate immune mechanisms that promote natural antitumor T cell responses are undefined. In human metastatic melanoma, there was a correlation between a type I interferon (IFN) transcriptional profile and T cell markers in metastatic tumor tissue. In mice, IFN-beta was produced by CD11c(+) cells after tumor implantation, and tumor-induced T cell priming was defective in mice lacking IFN-alpha/beta R or Stat1. IFN signaling was required in the hematopoietic compartment at the level of host antigen-presenting cells, and selectively for intratumoral accumulation of CD8 alpha(+) dendritic cells, which were demonstrated to be essential using Batf3(-/-) mice. Thus, host type I IFNs are critical for the innate immune recognition of a growing tumor through signaling on CD8 alpha(+) DCs.
引用
收藏
页码:2005 / 2016
页数:12
相关论文
共 57 条
[1]   Tolerization of tumor-specific T cells despite efficient initial priming in a primary murine model of prostate cancer [J].
Anderson, Michael J. ;
Shafer-Weaver, Kimberly ;
Greenberg, Norman M. ;
Hurwitz, Arthur A. .
JOURNAL OF IMMUNOLOGY, 2007, 178 (03) :1268-1276
[2]   An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesions [J].
Anichini, A ;
Molla, A ;
Mortarini, R ;
Tragni, G ;
Bersani, I ;
Di Nicola, M ;
Gianni, AM ;
Pilotti, S ;
Dunbar, R ;
Cerundolo, V ;
Parmiani, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (05) :651-667
[3]   Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy [J].
Apetoh, Lionel ;
Ghiringhelli, Francois ;
Tesniere, Antoine ;
Obeid, Michel ;
Ortiz, Carla ;
Criollo, Alfredo ;
Mignot, Gregoire ;
Maiuri, M. Chiara ;
Ullrich, Evelyn ;
Saulnier, Patrick ;
Yang, Huan ;
Amigorena, Sebastian ;
Ryffel, Bernard ;
Barrat, Franck J. ;
Saftig, Paul ;
Levi, Francis ;
Lidereau, Rosette ;
Nogues, Catherine ;
Mira, Jean-Paul ;
Chompret, Agnes ;
Joulin, Virginie ;
Clavel-Chapelon, Francoise ;
Bourhis, Jean ;
Andre, Fabrice ;
Delaloge, Suzette ;
Tursz, Thomas ;
Kroemer, Guido ;
Zitvogel, Laurence .
NATURE MEDICINE, 2007, 13 (09) :1050-1059
[4]   Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway [J].
Basu, S ;
Binder, RJ ;
Suto, R ;
Anderson, KM ;
Srivastava, PK .
INTERNATIONAL IMMUNOLOGY, 2000, 12 (11) :1539-1546
[5]   Cutting edge:: Conventional CD8α+ dendritic cells are generally involved in priming CTL immunity to viruses [J].
Belz, GT ;
Smith, CM ;
Eichner, D ;
Shortman, K ;
Karupiah, G ;
Carbone, FR ;
Heath, WK .
JOURNAL OF IMMUNOLOGY, 2004, 172 (04) :1996-2000
[6]   Combinational FLt3 ligand and granulocyte macrophage colony-stimulating factor treatment promotes enhanced tumor infiltration by dendritic cells and antitumor CD8+ T-cell cross-priming but is ineffective as a therapy [J].
Berhanu, Aklile ;
Huang, Jian ;
Alber, Sean M. ;
Watkins, Simon C. ;
Storkus, Walter J. .
CANCER RESEARCH, 2006, 66 (09) :4895-4903
[7]   Tumor antigens [J].
Boon, T ;
Old, LJ .
CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (05) :681-683
[8]   Selective Expression of the Chemokine Receptor XCR1 on Cross-presenting Dendritic Cells Determines Cooperation with CD8+ T Cells [J].
Dorner, Brigitte G. ;
Dorner, Martin B. ;
Zhou, Xuefei ;
Opitz, Corinna ;
Mora, Ahmed ;
Guettler, Steffen ;
Hutloff, Andreas ;
Mages, Hans W. ;
Ranke, Katja ;
Schaefer, Michael ;
Jack, Robert S. ;
Henn, Volker ;
Kroczek, Richard A. .
IMMUNITY, 2009, 31 (05) :823-833
[9]   Interferons, immunity and cancer immunoediting [J].
Dunn, Gavin P. ;
Koebel, Catherine M. ;
Schreiber, Robert D. .
NATURE REVIEWS IMMUNOLOGY, 2006, 6 (11) :836-848
[10]   A critical function for type I interferons in cancer immunoediting [J].
Dunn, GP ;
Bruce, AT ;
Sheehan, KCF ;
Shankaran, V ;
Uppaluri, R ;
Bui, JD ;
Diamond, MS ;
Koebel, CM ;
Arthur, C ;
White, JM ;
Schreiber, RD .
NATURE IMMUNOLOGY, 2005, 6 (07) :722-729